Syndax Pharmaceuticals reports inducement grant under Nasdaq listing rule 5635(c)(4)
SNDX•Syndax Pharmaceuticals reported an inducement grant under Nasdaq Listing Rule 5635(c)(4).
1. Inducement grant
Syndax Pharmaceuticals reported an inducement grant under Nasdaq Listing Rule 5635(c)(4).
